p42.3 gene expression in gastric cancer cell and its protein regulatory network analysis

Jianhua Zhang1, Chunlei Lu, Zhigang Shang

  • 1Department of Biomedical Engineering, School of Electrical Engineering, Zhengzhou University, Zhengzhou, Henan Province 450001, China.

Abstract

Insights

This study analyzed p42.3 gene expression and its regulatory network in gastric cancer (GC). The optimal pathway involves Ras, Raf-1, MEK, MAPK, and other proteins crucial for tumor development.

Area of Science:

  • Molecular Biology
  • Bioinformatics
  • Cancer Research

Background:

  • Gastric cancer (GC) is a significant health concern.
  • Understanding gene expression and protein function is crucial for GC research.
  • The p42.3 gene's role in GC requires further elucidation.

Purpose of the Study:

  • Analyze p42.3 gene expression in gastric cancer cells.
  • Determine the relationship between p42.3 protein structure and function.
  • Establish the p42.3 protein regulatory network and identify the optimal pathway.

Main Methods:

  • Gene expression analysis using RT-PCR and Western Blot.
  • Bioinformatics and MATLAB for protein structure-function analysis.
  • Bayesian networks to model and find the optimal regulatory pathway.

Main Results:

  • p42.3 expression is higher in G1 and M phases than in S and G2 phases.
  • Established spatial coordinate systems for p42.3 protein domains.
  • Identified the optimal regulatory pathway involving Ras, Raf-1, MEK, MAPK, tubulin, spindle, and centromere proteins in GC.

Conclusions:

  • p42.3 protein is vital in gastric cancer generation and development.
  • Identifying the p42.3 action pathway is significant for understanding GC mechanisms.
  • This research provides a foundation for further mechanistic studies in GC.